Press Contact
Ellen Mullally
Phone: 410-992-3124
Email: emullally@paltmed.org
JAMDA
January 9, 2020
Showing 4501 - 4510 of 8235 results
JAMDA
January 9, 2020
The Role of C-Reactive Protein in the Pain and Cognition Relationship
JAMDA
January 9, 2020
Landscape of Sarcopenia Research (1989‒2018): A Bibliometric Analysis
JAMDA
January 9, 2020
Impact of Overweight and Obesity on Functional and Clinical Outcomes of Early Parkinson's Disease
To determine whether being overweight or obese contributes to disease progression and functional status in Parkinson's disease (PD).
JAMDA
January 8, 2020
Association Between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease
To identify the association between the use of acetylcholinesterase inhibitors (AChEIs) and risk of osteoporotic fractures in older persons with Alzheimer's disease (AD).
JAMDA
January 8, 2020
Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews
Polypharmacy is widespread among older people, but the adverse outcomes associated with it are unclear. We aim to synthesize current evidence on the adverse health, social, medicines management, and health care utilization outcomes of polypharmacy in older people.
JAMDA
January 8, 2020
Peak Expiratory Flow and the Risk of Injurious Falls in Older Adults: The Role of Physical and Cognitive Deficits
Previous studies showed that peak expiratory flow (PEF) is associated with health-related outcomes in advanced age, but the extent to which it may be related to falls risk remains unclear. We aimed to detect the association between PEF and injurious falls in older adults and to explore the role of cognitiv...
JAMDA
January 7, 2020
A Systematic Review of Nursing Home Palliative Care Interventions: Characteristics and Outcomes
Despite recommendations to integrate palliative care into nursing home care, little is known about the most effective ways to meet this goal.
JAMDA
January 6, 2020
Safety and Effectiveness of Direct Oral Anticoagulants vs Warfarin in People With Atrial Fibrillation and Dementia
To determine risks of embolic events, bleeding, and mortality with direct oral anticoagulants (DOACs) vs warfarin in people with atrial fibrillation (AF) and dementia.
JAMDA
January 6, 2020